灌木薄荷与扩散猪草提取物对CYP1A2、CYP2D6和CYP3A4酶活性的差异性影响
研究采用重组CYP450和荧光筛选法,检测灌木薄荷(HS)与扩散猪草(BD)粗水提物对CYP1A2、CYP2D6和CYP3A4的可逆性与时间依赖性抑制(TDI)及抑制动力学参数,并用UPLC-MS鉴定多酚类成分。结果显示两提取物对各酶抑制强弱不同,均表现TDI,提示与上述酶底物药物联用可能存在草药-药物相互作用。
要点
- HS对CYP2D6抑制最强(1.39±0.01µg/mL),对CYP1A2最弱(3.68±0.10µg/mL)。
- BD对CYP3A4抑制最强(7.36±0.94µg/mL),对CYP2D6最弱(17.79±1.02µg/mL)。
- 两提取物对CYP1A2、CYP2D6、CYP3A4均呈时间依赖性抑制,联用需警惕相互作用。
核心结论
- HS与BD粗水提物可可逆且时间依赖性地抑制CYP1A2、CYP2D6和CYP3A4。
- 与上述酶底物药物联用时应谨慎,存在潜在草药-药物相互作用。
研究设计与样本
- 采用重组CYP450抑制实验与荧光筛选法,测定HS和BD提取物对CYP1A2、CYP2D6、CYP3A4的可逆抑制与TDI。
- 估算抑制动力学参数Ki和Kinact,并用UPLC-MS(ESI负离子,Synapt G2,PDA检测)鉴定粗提物中多酚类化合物。
主要发现
- HS对CYP1A2、CYP2D6、CYP3A4的抑制强度分别为3.68±0.10µg/mL、1.39±0.01µg/mL、2.36±0.57µg/mL。
- BD对CYP1A2、CYP2D6、CYP3A4的抑制强度分别为9.48±0.78µg/mL、17.79±1.02µg/mL、7.36±0.94µg/mL。
- HS和BD提取物对所有测试CYP均表现出时间依赖性抑制。
- UPLC-MS鉴定出咖啡酸、芦丁、槲皮素、柠檬酸、阿魏酸和葡萄糖酸等主要酚类候选成分。
- 体内预测显示HS和BD提取物与其他药物联用可能引起显著相互作用。
关键数值与推荐
- HS对CYP1A2、CYP2D6、CYP3A4的抑制 potency 分别为3.68±0.10µg/mL、1.39±0.01µg/mL、2.36±0.57µg/mL。
- BD对CYP1A2、CYP2D6、CYP3A4的抑制 potency 分别为9.48±0.78µg/mL、17.79±1.02µg/mL、7.36±0.94µg/mL。
- 两提取物对CYP1A2、CYP2D6和CYP3A4均显示TDI。
临床怎么用
- 临床使用含HS或BD的草药制剂时,应评估与CYP1A2、CYP2D6、CYP3A4底物药物联用的相互作用风险。
- 对治疗窗窄的上述酶底物药物,联用含HS或BD的制剂需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNO-PHARMACOLOGICAL RELEVANCE: Hyptis suaveolens (L) Poit and Boerhavia diffusa Linn are medicinal herbal plants commonly found in the tropics and sub-tropics. They are used to treat various conditions among them boils, dyslipidaemia, eczema, malaria, jaundice and gonorrhoea. Thus, the herbal medicinal extracts are now found as part of some commercial herbal formulations. There has not been adequate characterization of these medicinal herbs on their effects on drug metabolising enzymes. AIM OF THE STUDY: To investigate the effects of extracts of Hyptis suaveolens (HS) and Boerhavia diffusa (BD) on activity of drug metabolising enzymes, CYP1A2, CYP2D6 and CYP3A4, as well predict their potential for herb-drug interaction. A secondary aim was to identify constituent compounds such as polyphenolics, in the crude extract preparations of Hyptis suaveolens and Boerhavia diffusa and measure them for activity. MATERIALS AND METHODS: CYP450 inhibition assays using recombinant CYP450 (rCYP) and fluorescence screening employing individual isozymes (CYP1A2, CYP2D6 and CYP3A4) were used to determine reversible- and time-dependent inhibition (TDI) profiles of extracts of Hyptis suaveolens and Boerhavia diffusa. Inhibition kinetic parameters, Ki and Kinact were also estimated. UPLC-MS employing a Synapt G2 (ESI negative) coupled to a PDA detector was used to identify polyphenolic compounds in crude extracts of Hyptis suaveolens and Boerhavia diffusa. RESULTS: The inhibitory potency of Hyptis suaveolens and Boerhavia diffusa extracts varied among the different enzymes, with CYP1A2 (3.68 ± 0.10µg/mL) being the least inhibited by HS compared to CYP2D6 (1.39 ± 0.01µg/mL) and CYP3A4 (2.36 ± 0.57µg/mL). BD was most potent on CYP3A4 (7.36 ± 0.94µg/mL) compared to both CYP2D6 (17.79 ± 1.02µg/mL) and CYP1A2 (9.48 ± 0.78µg/mL). Extracts of Hyptis suaveolens and Boerhavia diffusa exhibited TDIs on all CYPs. The most prominent phenolic candidates identified in both medicinal herbs using UPLC-MS analysis included caffeic acid, rutin, quercetin, citric acid, ferulic acid and gluconic acid. These phenolic compounds are thought to potentially give HS and BD their therapeutic effects and inhibitory characteristics affecting CYP450 activities. In vivo predictions showed the potential for HS and BD extracts to cause significant interactions if co-administered with other medications. CONCLUSIONS: The study reveals that crude aqueous extracts of HS and BD potentially inhibit drug metabolising isozymes CYP1A2, CYP2D6 and CYP3A4 in a reversible and time-dependent manner. Thus care should be taken when these extracts are co-administered with drugs that are substrates of CYP1A2, CYP2D6 and CYP3A4.
引用
- Ekow Thomford N, Dzobo K, Adu F, et al. Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6 and CYP3A4 enzymes. J Ethnopharmacol. 2017. PMID: 28942133. doi:10.1016/j.jep.2017.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。